Details of the Drug

General Information of Drug (ID: DMDI3B4)

Drug Name

VI-1121

Indication

Disease Entry	ICD 11	Status	REF
Alzheimer disease	8A20	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT01428362) VI-1121 for the Treatment Alzheimer's Disease. U.S. National Institutes of Health.